Enhanze
Navigation Links
Enhanze in Medical News
Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Added to Nasdaq Biotech Index
...covering the family of human enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform designed to increase the absor...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10...Baxter Reports Strong Third Quarter Sales and Earnings
...wn as KIOVIG(TM) in Europe). For patients using GAMMAGARD LIQUID 10% - currently administered intravenously - subcutaneous administration with enhanze Technology may increase convenience and improve the dispersion of the therapy. -- A collaboration with DEKA Research & Development Corp. and HHD...Enhanze in Medical Technology
- Co-Injection of rHuPH20 with Humira Estimated to Increase the
Maximal Steady State Subcutaneous Bioavailability from 64% to 100%
-
SAN DIEGO, July 09, 2007 /PRNewswire-FirstCall/ -- Halozyme
Therapeutics, Inc. , a biopharmaceutical company developing and
commercializing recombinant human enzymes...
...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...
...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...
...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape......nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
... Phase I/II data showed that enhanze Technology(TM) enabled subcutaneous administrat... administered combination of GAMMAGARD LIQUID with enhanze Technology was 92 percent of the traditional, mont...ivotal Phase III trial using GAMMAGARD LIQUID with enhanze Technology pending discussions with regulatory aut...... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Enhanze in Biological Technology
Halozyme Receives $5.5 Million Payment From Baxter
...s that affect the extracellular matrix. Halozyme's enhanze Technology is a novel drug delivery platform desi...e company has key partnerships with Roche to apply enhanze Technology to Roche's biological therapeutic compo... to 13 targets and with Baxter BioScience to apply enhanze Technology to Baxter's biological therapeutic comp...Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
...neous (SC) administration of GAMMAGARD LIQUID with enhanze Technology is an investigational study and when ap...gics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
...n and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%......nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Present at Upcoming Investor Conferences
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Host Research Day for Investors and Analysts
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Present at Upcoming Investor Conferences
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Other TagsStemSepIMPACTIMPACTIMPACTIMPACTIMPACTPhosphateCarbohydrateOther Contentsilluminatoridentityidentityidentityidentityidentityidentityileumileumimprintingimprintingimprintingimmunoprecipitationimmunoprecipitationsilicositusitusitusitusitusitusitusituvitrovitrovitrovitrovitrovitrovitrovitrovitro
NanoMateStemSepNovaBlueMetaMorphIMPACTNADPHSkeletalPhosphateDIGIVIEWCarbohydrateInterspeciesOdysseyMetaMineNDPase
(Date:11/8/2009)..., Nov. 8 Today, the nat...ives on passing, the Affordable Health Care for Am... important step in reforming America,s healthcare ...ors Annual Meeting in Providence (RI), mayors from...h care reform principles of reducing the long-term...
(Date:11/8/2009)...ses House Passage of Health Care Reform Bill ,... improve coverage for all Americans ,, HARRISB..., SUMMARY: Last night the United States House o...rm legislation that would strengthen Medicare for ...ies that prices millions of Americans out of affor...
(Date:11/8/2009)...ts and Crushing Taxes Nail Nation,s Job Creators ,... In response to U.S. House passage of the health c...eneurship Council (SBE Council) president & CE...,, "Make no mistake, those voting for H.R. 3962...gher costs and crushing taxes and penalties. Even ...
(Date:11/8/2009)... 3D Global Solutions is pleased to announ... the proposal effort for ReSound who recently rece...ng Aid contract. The award includes not only the V... Defense and other federal agencies. , ...9 -- 3D Global Solutions is pleased to announce th...
(Date:11/8/2009)..., Nov. 7 Today, the Hou...ptur, Dahlkemper, Smith, Ellsworth and Lipinski am... Act" (H.R. 3962). The amendment maintains the cur...tion and for benefits packages that include aborti...receive affordability credits and those who do not...
Breaking Medicine News(10 mins):Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2[0] The Nation's Mayors Commend House Passage of Health Reform Bill[1] AARP Pennsylvania Key Vote News Alert[0] House Passes Health Care Bill on the Backs of Small Businesses[0] 3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract [1] Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill
(Date:11/4/2009)...HILADELPHIA Although scientists are reluctant to ...n method, evidence continues to grow about its pro...published in Cancer Prevention Research , a journ..., which suggests some reduction in oral cancer. ,...f medicine in the Department of Thoracic/Head and ...
(Date:11/4/2009)...eavy traffic corridors in the cities of Long Beach...roportion of preventable childhood asthma, and the...n the disease has likely been underestimated, acco... California (USC). , The study, which appears i...blic Health , estimated that nine percent of all c...
(Date:11/4/2009)...ancouver, BC - Lowly bacteria, it turns out, hold ...turing plants around the world clean up toxic wast..., specifically RDX, were invented back in World Wa...decades. These high-energy compounds are often us...ful version of TNT. , But with increased knowl...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 1BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 3BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 4BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 1DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 2DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 4DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 6AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 1AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 2AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |